In this episode, I break down the major trials debuting at the Critical Care Reviews 2026 meeting, focusing on the game-changing ARISE Fluids trial and its impact on the 30 mL/kg sepsis mandate. I also dive into the latest data on sodium bicarbonate use in cardiac arrest and metabolic shock, before correcting a major acid-base misconception regarding DKA resolution.

EMCrit Project by Scott Weingart, MD FCCM.